Biontech Se ADR
(BNTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BNTX | RPRX | INCY | ||
| Company | Biontech Se ADR | Royalty Pharma Plc Cl A | Incyte Corp | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 106.86 | 44.64 | 108.50 | ||
| High | 108.05 | 44.90 | 108.81 | ||
| Low | 106.86 | 44.37 | 106.58 | ||
| Latest | 108.30 | 44.44 | 108.77 | ||
| Change | +1.68 | -0.21 | +0.38 | ||
| % Change | +1.58% | -0.47% | +0.35% | ||
| Volume | 66,701 | 179,545 | 181,774 | ||
| 20-Day Average Volume | 1,027,353 | 3,791,677 | 1,700,344 | ||
| Previous Close | 106.62 | 44.65 | 108.39 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 111.06 | 41.29 | 103.75 | ||
| 20-Day Raw Stochastic | 33.84% | 91.53% | 91.06% | ||
| 20-Day Relative Strength | 51.77 | 72.44 | 57.83 | ||
| Weighted Alpha | -4.56 | +42.31 | +60.92 | ||
| Today's Opinion | 24% Buy | 100% Buy | 100% Buy | ||
| Previous Opinion | 24% Buy | 100% Buy | 100% Buy | ||
| Last Month's Opinion | 80% Sell | 100% Buy | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.23% since 02/02/26 | +4.84% since 02/02/26 | +4.91% since 02/02/26 | ||
| Low | 105.42 on 02/05/26 | 42.28 on 02/03/26 | 100.72 on 02/03/26 | ||
| High | 110.11 on 02/04/26 | 44.92 on 02/06/26 | 108.52 on 02/06/26 | ||
| 1-Month | |||||
| %Chg | +7.71% since 01/09/26 | +10.56% since 01/09/26 | +0.79% since 01/09/26 | ||
| Low | 99.13 on 01/12/26 | 38.86 on 01/20/26 | 98.85 on 01/28/26 | ||
| High | 124.00 on 01/22/26 | 44.92 on 02/06/26 | 108.58 on 01/16/26 | ||
| 3-Month | |||||
| %Chg | +4.27% since 11/07/25 | +15.17% since 11/07/25 | +1.63% since 11/07/25 | ||
| Low | 91.11 on 12/18/25 | 37.31 on 11/24/25 | 93.54 on 12/12/25 | ||
| High | 124.00 on 01/22/26 | 44.92 on 02/06/26 | 112.29 on 01/07/26 | ||
| 6-Month | |||||
| %Chg | -3.69% since 08/08/25 | +18.18% since 08/08/25 | +37.40% since 08/08/25 | ||
| Low | 90.12 on 09/12/25 | 34.08 on 09/08/25 | 78.20 on 08/11/25 | ||
| High | 124.00 on 01/22/26 | 44.92 on 02/06/26 | 112.29 on 01/07/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 24,008,904 | 25,773,678 | 21,279,448 | ||
| Shares Outstanding, K | 225,182 | 577,238 | 196,323 | ||
| Annual Sales | 2,976,970,000 | 2,263,580,000 | 4,241,220,000 | ||
| Annual Net Income | -719,920,000 | 858,980,000 | 32,610,000 | ||
| Last Quarter Sales | 1,775,440,000 | 609,290,000 | 1,365,980,000 | ||
| Last Quarter Net Income | -33,550,000 | 288,220,000 | 424,170,000 | ||
| 60-Month Beta | 1.49 | 0.42 | 0.82 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.14 on 11/03/25 | 1.17 on 11/05/25 | 2.26 on 10/28/25 | ||
| Latest Earnings Date | 03/09/26 | 02/11/26 | 02/10/26 | ||
| Most Recent Dividend | 3.084 on 06/02/22 | 0.220 on 11/14/25 | N/A | ||
| Next Ex-Dividends Date | 06/02/22 | 02/20/26 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 9.76 | 19.32 | ||